Athersys, Inc / New financial data

Symbol
ATHX on OTC
Industry
Pharmaceutical Preparations
Location
3201 Carnegie Avenue, Cleveland, Ohio
State of incorporation
Delaware
Fiscal year end
December 31
Former names
BTHC VI Inc (to 9/6/2007)
Latest financial report
Q3 2023 - Nov 16, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 17.1 % -80.9%
Return On Equity 117 % -95.8%
Return On Assets -223 % -20.7%
Operating Margin -51.6 K % -3547%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 61.7 M shares +377%
Common Stock, Shares, Outstanding 26.8 M shares +107%
Entity Public Float 71.2 M USD -61.5%
Common Stock, Value, Issued 27 K USD +108%
Weighted Average Number of Shares Outstanding, Basic 20.7 M shares +99.4%
Weighted Average Number of Shares Outstanding, Diluted 20.7 M shares +99.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 81 K USD -98.7%
Revenue from Contract with Customer, Excluding Assessed Tax 81 K USD -100%
Research and Development Expense 30 M USD -58.9%
General and Administrative Expense 10.9 M USD -34%
Costs and Expenses 41.8 M USD -54%
Operating Income (Loss) -41.8 M USD +50.9%
Nonoperating Income (Expense) 4.01 M USD +31.7%
Net Income (Loss) Attributable to Parent -37.5 M USD +53.8%
Earnings Per Share, Basic -1.57 USD/shares +72.9%
Earnings Per Share, Diluted -2.57 USD/shares +59.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.02 M USD -92.6%
Accounts Receivable, after Allowance for Credit Loss, Current 716 K USD -49.4%
Assets, Current 2.23 M USD -89.3%
Property, Plant and Equipment, Net 4.24 M USD -22.1%
Operating Lease, Right-of-Use Asset 26 K USD -99.7%
Assets 7.43 M USD -79.1%
Accounts Payable, Current 9.3 M USD
Employee-related Liabilities, Current 890 K USD -42.7%
Accrued Liabilities, Current 1.32 M USD +41.9%
Contract with Customer, Liability, Current 150 K USD
Liabilities, Current 38.6 M USD -0.27%
Contract with Customer, Liability, Noncurrent 5.2 M USD 0%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 119 K USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.21 M USD
Retained Earnings (Accumulated Deficit) -680 M USD -5.83%
Stockholders' Equity Attributable to Parent -36.4 M USD -119%
Liabilities and Equity 7.43 M USD -79.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.97 M USD +70.4%
Net Cash Provided by (Used in) Financing Activities -56 K USD -101%
Net Cash Provided by (Used in) Investing Activities 105 K USD
Common Stock, Shares Authorized 600 M shares 0%
Common Stock, Shares, Issued 26.8 M shares +107%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.92 M USD +62.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.8 M USD -86.5%
Deferred Tax Assets, Valuation Allowance 123 M USD +15.6%
Deferred Tax Assets, Gross 124 M USD +15.3%
Operating Lease, Liability 8.69 M USD -11.4%
Depreciation 1.01 M USD -41.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -36.3 M USD +55.3%
Lessee, Operating Lease, Liability, to be Paid 12.5 M USD -13.7%
Property, Plant and Equipment, Gross 14.6 M USD -8.14%
Operating Lease, Liability, Current 7.79 M USD +822%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.39 M USD -11.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.5 M USD -22.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.85 M USD -19.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.4 M USD +1.01%
Deferred Tax Assets, Operating Loss Carryforwards 80.4 M USD +1.11%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.43 M USD +1.99%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.73 M USD -0.97%
Share-based Payment Arrangement, Expense 2.9 M USD -57.4%
Interest Expense 211 K USD